Skip to main content
. Author manuscript; available in PMC: 2019 Nov 11.
Published in final edited form as: Clin Otolaryngol. 2019 Apr 1;44(4):639–643. doi: 10.1111/coa.13316

TABLE 3.

Univariable and multivariable Cox regression analyses for survival benefit (PFS and OS)

Univariable
Multivariable
HR (95% CI) Signif HR(95% CI) Signif
PFS
 Age at treatment  0.99 (0.95, 1.02) 0.44 0.98 (0.95, 1.02) 0.35
 Number of cycles  0.97 (0.90, 1.04) 0.43 0.97 (0.90, 1.04) 0.34
 Received CTX in the past
  No Ref.
  Yes  0.84 (0.43, 1.67) 0.63 0.75 (0.37, 1.52) 0.43
 Number of prior lines of palliative chemo
  None Ref.
  ≥1  0.98 (0.54, 1.78) 0.96 0.98 (0.54, 1.77) 0.93
OS
 Age at treatment  0.99 (0.96, 1.02) 0.48 0.98 (0.95, 1.02) 0.34
 Number of cycles  0.85 (0.78, 0.92) <0.001 0.84 (0.77, 0.91) <0.001
 Received CTX in the past
  No Ref.
  Yes  0.90 (0.48, 1.71) 0.75 0.60 (0.30, 1.20) 0.15
 Number of prior lines of palliative chemo
  None Ref.
  ≥1  1.03 (0.58, 1.83) 0.91 0.91 (0.51, 1.64) 0.76

CI, confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival; Ref.,reference; Signif, significance.